Actions that will go into action today (December 9)

0


HCL Technologies

HCL Technologies (HCL), a leading global technology company, and Deutsche Apotheker- und Ärztebank eG (apoBank), Germany’s largest cooperative primary bank, have signed an agreement with Atruvia AG, to acquire the IT consulting company Gesellschaft for Banksysteme GmbH (gbs). The transaction is expected to close in January 2022, subject to closing conditions, including regulatory approvals. After the closing, HCL will hold 51%, while apoBank will hold 49% of the capital of gbs. apoBank is currently a 10 percent shareholder of gbs.

Neogen chemicals

The board of directors of Neogen Chemicals, a leading manufacturer of specialty lithium bromine chemicals, has approved the issuance of up to 16.04 lakh shares on a preferential basis at a price issue of 1,402.12 per share totaling approximately 225 crore. The proposed issue will incorporate some of the high quality reputable institutional investors such as SBI Mutual Fund, Axis Mutual Fund, Plutus Wealth Management LLP and White Oak Capital.

RailTel Corporation of India

RailTel Corporation of India has received a work order from Ircon International for the design, supply, installation, testing and commissioning of a tunnel communication system comprising an emergency call and a telephone for service, CCTV, tunnel radio and public address system in tunnel environment on Dharam – Banihal section of Jammu Kashmir Rail Link Project under Ferozepur Division of Northern Railway at a total cost of 210, 77 crore (GST included). All work must be completed within 12 months.

Gland Pharma

Gland Pharma, a pharmaceutical company specializing in generic injectables, has received interim approval from the United States Food and Drug Administration (FDA) for Cangrelor for Injection, 50 mg single-dose vials / vial. Gland Pharma believes that it is among the first to file a request for this product and that it could be eligible for 180 days of generic drug exclusivity. Gland Pharma will launch the product with its business partner upon receipt of final approval.

Calcom Vision

The board of directors of Calcom Vision has approved the issuance and allotment of shares on a preferential basis, totaling up to 10 crore. The recipients are Micro Strategies Fund – A program of Old Bridge, Massachusetts Institute of Technology, and 238 Plan Associates LLC. The board of directors also approved the issuance and allotment of shares, pursuant to the conversion of a loan, on a preferential basis, totaling up to 5 crore yen to Sushil Kumar Malik and Calcom Electronics, owned to the Promoter and Promoter Group category, subject to shareholder approval.

Dishman Carbogen Amcis

Dishman Carbogen Amcis, a Global Pharmaceutical Industry Outsourcing Partner, Welcomes Results of New Clinical Research Study Showing Oral 25-Hydroxyvitamin D3 (Calcifediol) May Correct Deficiency / Deficiency vitamin D in patients with Covid-19 and that it resulted in improved immune function by increasing the percentages of lymphocytes in the blood. The research was supervised by the Tehran University of Medical Sciences and Boston University School of Medicine and funded in part by a grant from Carbogen Amcis BV, a wholly-owned subsidiary of Dishman Carbogen Amcis.

NHPC

The board of directors of NHPC has given its approval to the merger / merger of Lanco Teesta Hydro Power Limited, which is a wholly owned subsidiary of the company, with the company under section 230-232 of the Law on companies of 2013 and other statutory provisions such as under the terms and conditions mentioned in the Scheme of Amalgamation (Scheme).

Venus remedies

Venus Remedies has received approval from the Indian government under the Production Linked Incentive Scheme (PLI) PLI 2.0 for Pharmaceutical Manufacturers Registered in India. Venus is one of 10 non-MSME Category C pharmaceutical companies that have received PLI program approval. In accordance with the program, the company will be eligible for an incentive for fiscal years 2022-23 to 2027-28, subject to meeting minimum investment criteria and on the basis of incremental sales of eligible products in accordance with the program guidelines.

Artemis health insurance services

Artemis Medicare Services has announced that the construction of a new tower (Tower – II) adjacent to the hospital building located in Gurugram with a capacity of 147 beds has been completed. The Tour-II will be operational gradually with immediate effect.

Karma Energy

The board of directors of Karma Energy has approved the divestment of the entire interest in a wholly owned subsidiary, namely Batot Hydro Power, subject to the approval of the members. The total consideration to be received from such elimination is ₹ 35 crore.

Action construction equipment

Action Construction Equipment has received an order for the supply of 38nos. Mobile crane at SPIC, defense R&D organization (Ministry of Defense) for a total consideration of approximately 6.51 crores.

Alankit

Alankit’s Board of Directors reviewed and approved the fundraising through the issuance of fully paid up share rights with a par value of 1 each, of the company, to eligible shareholders of the company to the date of registration (to be notified later), for a maximum amount not exceeding 50 crore.


Share.

Comments are closed.